We assessed the effect of various COVID-19 vaccination strategies on health outcomes in Ghana by using an age-stratified compartmental model. We stratified the population into 3 age groups: \u3c25 years, 25–64 years, and ≥65 years. We explored 5 vaccination optimization scenarios using 2 contact matrices, assuming that 1 million persons could be vaccinated in either 3 or 6 months. We assessed these vaccine optimization strategies for the initial strain, followed by a sensitivity analysis for the Delta variant. We found that vaccinating persons \u3c25 years of age was associated with the lowest cumulative infections for the main matrix, for both the initial strain and the Delta variant. Prioritizing the elderly (≥65 years of age) was associa...
In a time dominated by the effects of the COVID-19 global pandemic, disease models become an in- val...
Revisiting the classical model by Ross and Kermack-McKendrick, the Susceptible–Infectious–Recovered ...
Coronavirus disease 2019 (COVID-19) vaccination has recently started worldwide. As the vaccine suppl...
We assessed the effect of various COVID-19 vaccination strategies on health outcomes in Ghana by usi...
BACKGROUND: The development and widespread use of an effective SARS-CoV-2 vaccine could prevent subs...
The worldwide inequitable access to vaccination claims for a re-assessment of policies that could mi...
The risk for severe illness and mortality from COVID-19 significantly increases with age. As a resul...
Objective To characterise the optimal targeting of age and risk groups for COVID-19 vaccines.Design ...
Although the primary and secondary vaccination rates in Korea account for over 75% of the total popu...
Background Vaccination has the proven effectiveness in reducing disease burden. As the emergency pr...
International audienceBackground When vaccines against the novel COVID-19 were available in Senegal,...
Objectives To investigate the impact of targeted vaccination strategies on morbidity and mortality d...
The approved coronavirus disease (COVID-19) vaccines reduce the risk of disease by 70–95%; however, ...
The countries of the African meningitis belt suffer from frequent epidemics due to meningococcal men...
International audienceBackground: The roll-out of COVID-19 vaccines is a multi-faceted challenge who...
In a time dominated by the effects of the COVID-19 global pandemic, disease models become an in- val...
Revisiting the classical model by Ross and Kermack-McKendrick, the Susceptible–Infectious–Recovered ...
Coronavirus disease 2019 (COVID-19) vaccination has recently started worldwide. As the vaccine suppl...
We assessed the effect of various COVID-19 vaccination strategies on health outcomes in Ghana by usi...
BACKGROUND: The development and widespread use of an effective SARS-CoV-2 vaccine could prevent subs...
The worldwide inequitable access to vaccination claims for a re-assessment of policies that could mi...
The risk for severe illness and mortality from COVID-19 significantly increases with age. As a resul...
Objective To characterise the optimal targeting of age and risk groups for COVID-19 vaccines.Design ...
Although the primary and secondary vaccination rates in Korea account for over 75% of the total popu...
Background Vaccination has the proven effectiveness in reducing disease burden. As the emergency pr...
International audienceBackground When vaccines against the novel COVID-19 were available in Senegal,...
Objectives To investigate the impact of targeted vaccination strategies on morbidity and mortality d...
The approved coronavirus disease (COVID-19) vaccines reduce the risk of disease by 70–95%; however, ...
The countries of the African meningitis belt suffer from frequent epidemics due to meningococcal men...
International audienceBackground: The roll-out of COVID-19 vaccines is a multi-faceted challenge who...
In a time dominated by the effects of the COVID-19 global pandemic, disease models become an in- val...
Revisiting the classical model by Ross and Kermack-McKendrick, the Susceptible–Infectious–Recovered ...
Coronavirus disease 2019 (COVID-19) vaccination has recently started worldwide. As the vaccine suppl...